Randomised controlled trials of proton beam therapy are neededBMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e3193 (Published 08 May 2012) Cite this as: BMJ 2012;344:e3193
- Ian H Kunkler, consultant in clinical oncology1
- 1Edinburgh Cancer Centre, Edinburgh EH4 2XU, UK
Epstein questions whether the investment of £250m (€307m; $405m) in two NHS UK proton facilities is premature.1 The ability of protons to confine the high dose volume to the tumour while minimising the dose to adjacent normal tissues is theoretically attractive in, for example, selected paediatric intracranial tumours, skull …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial